CIK 0000944809
- Accelerated filer
OPKO HEALTH, INC.
Sign in to watch- Ticker
- OPK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 752402409
- Phone
- +1 305-575-4181
- Business address
- 4400 BISCAYNE BLVD., MIAMI, FL, 33137
- Former names
- EXEGENICS INC, eXegenics Inc, CYTOCLONAL PHARMACEUTICS INC /DE
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $24,577
- in 1 filing
Net −$24,577. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-07-14 | Borisy Alexis Director | Grant or award · Stock Option (Right to Buy) | −30,000 | 30,000 | ||
| 2022-06-22 | Nabel Gary J. Chief Innovation Officer | Purchase | +1,491 | $2.50 | $4K | 19,779,005 |
| 2022-06-22 | Nabel Gary J. Chief Innovation Officer | Purchase | +65,280 | $2.50 | $163K | 19,844,285 |
| 2022-06-22 | Nabel Gary J. Chief Innovation Officer | Purchase | +13,229 | $2.50 | $33K | 19,857,514 |
| 2022-06-22 | Nabel Gary J. Chief Innovation Officer | Purchase | +31,023 | $2.50 | $77K | 19,808,537 |
| 2022-06-22 | Nabel Gary J. Chief Innovation Officer | Purchase | +15,200 | $2.50 | $38K | 19,823,737 |
| 2022-06-22 | Nabel Gary J. Chief Innovation Officer | Purchase | +33,777 | $2.50 | $84K | 19,857,514 |
| 2022-06-22 | Nabel Gary J. Chief Innovation Officer | Purchase | +80,000 | $2.47 | $198K | 80,000 |
| 2022-06-21 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +29,715 | $2.39 | $71K | 196,436,409 |
| 2022-06-21 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +4,000 | $2.39 | $10K | 196,440,409 |
| 2022-06-21 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +49,778 | $2.39 | $119K | 196,490,187 |
| 2022-06-21 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +40,009 | $2.40 | $96K | 196,530,196 |
| 2022-06-21 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +68,340 | $2.40 | $164K | 196,598,536 |
| 2022-06-21 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +7,466 | $2.41 | $18K | 196,606,002 |
| 2022-06-21 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +692 | $2.41 | $2K | 196,606,694 |
| 2022-06-16 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +9,560 | $2.29 | $22K | 196,316,254 |
| 2022-06-16 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +15,866 | $2.29 | $36K | 196,332,120 |
| 2022-06-16 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +4,804 | $2.30 | $11K | 196,336,924 |
| 2022-06-16 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +3 | $2.30 | $7 | 196,336,927 |
| 2022-06-16 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +1,429 | $2.31 | $3K | 196,338,356 |
Page 20 of 33 · 653 trades